Automotive Digital Response Management

ResponseLogix Journal

Subscribe to ResponseLogix Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get ResponseLogix Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

ResponseLogix Authors: Catherine Edwards, Maureen O'Gara, Todd Ignasiak, Jeremy Geelan, Nati Shalom

Related Topics: ResponseLogix Journal, Biotech News Journal, Pharmaceutical News

News Feed Item

BioFlorida Elects 12 New Directors to Its Board

BioFlorida, Florida’s statewide trade association for the bioscience industry, has added 12 new directors to its Board of Directors. The unanimous vote took place on March 30, 2009 at the Annual Member Meeting at the Hyatt Regency Orlando International Airport in Orlando. Of the 39 members of the Board, 70% represent research and development companies and institutions.

BioFlorida’s Board of Directors guides the organization in business development, education and workforce, and outreach for the bioscience industry throughout the state. The Board also advocates for the industry by meeting with legislators on both the federal and state level to cultivate a supportive climate for bioscience growth.

“These 12 individuals further enhance our already impressive Board. We’re thankful for their service and look forward to a prosperous year,” said Tom McLain, BioFlorida’s Chairman of the Board and President, Claro Scientific.

This year, BioFlorida will be hosting the Florida Pavilion at the Biotechnology Industry Organization (BIO) International Convention on May 18-21 in Atlanta, GA. As ambassadors to Florida's growing biotechnology industry, these directors will be present to showcase the state's advances to an audience of approximately 20,000.

“As the BIO state affiliate, BioFlorida promotes the convention’s mission to ‘Heal, Fuel and Feed The World’,” McLain said.

2009 BioFlorida New Directors
Maggie Dias, Thermo Fisher Scientific
Santiago Galvez, Beckman Coulter
Elizabeth Goodman, Genentech
Claudia Hillinger, Max Planck Florida Institute
Thad Seymour, Lake Nona
Randy Scott, NovaMin
John Spencer, Independent Director
Thomas Stevens, Ernst & Young
Jim Talton, Nanotherapeutics
Daniel Wahby, Eli Lilly and Company
Stephanie Warrington, Xhale
Claudia Zylberberg, AppliChem
These individuals join:
Russell Allen, BioFlorida
Rod Casto, University of South Florida
Bart Chernow, University of Miami
Anne Chinoda, Florida's Blood Centers
Les Croland, Edwards Angell Palmer & Dodge
David Day, University of Florida
Stephanie Finnegan, Goodwin Biotechnology
Richard Hall, ACC Hall International
Richard Houghten, Torrey Pines Institute for Molecular Studies
Patrick Kay, Alexandria Real Estate Equities
Ken Kirby, TransDermal Technologies
Gary Margules, Nova Southeastern University
Tom McLain, Claro Scientific
Jim Mulé, H. Lee Moffitt Cancer Center
Tom O'Neal, University of Central Florida
Mike Nicoletta, Medtronic
Harry Orf, Scripps Florida
Gregory Nelson, Novak Druce + Quigg
James Patrick, National Healing Corporation
Mel Rothberg, Dharma Biomedical
David Saliwanchik, Saliwanchik Lloyd & Saliwanchik
Jack Sullivan, Florida Research Consortium
Claire Thuning-Roberson, Altor Bioscience
Susan Washer, Applied Genetic Technologies Corporation
Michael Wasserman, H.I.G. Ventures
Brenda Workman, Enterprise Florida
Art Wotiz, NovaBone

Through the leadership of BioFlorida’s Board of Directors and full membership, Florida has become one of the most competitive bioscience states in the nation. In 2007 and 2008, Fierce Biotechnology ranked Florida as one of the top five regions worldwide for attracting biotechnology companies.

About BioFlorida

BioFlorida is Florida’s statewide trade association for the bioscience industry providing advocacy, business development and communications services for more than 200 member companies. Our mission is to be the voice of the bioscience industry and the advocate for our member organizations. Bringing knowledge and resources to Florida’s bioscience community, BioFlorida supports the health, agricultural and energy sectors of biotechnology as well as the pharmaceutical and medical technology fields.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.